Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases (Q31886177)

4 July 2017

1 reference

title

Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases (English)

1 reference

4 July 2017

cardiovascular disease

1 reference

Goumas G

1

1 reference

4 July 2017

Tentolouris C

2

1 reference

4 July 2017

Tousoulis D

3

1 reference

4 July 2017

Stefanadis C

4

1 reference

4 July 2017

Toutouzas P

5

1 reference

4 July 2017

1 February 2001

1 reference

4 July 2017

1 reference

4 July 2017

154

1 reference

4 July 2017

2

1 reference

4 July 2017

255-267

1 reference

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Vascular endothelial cells synthesize nitric oxide from L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide: mediator, murderer, and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Role of nitric oxide in exercise-induced vasodilation of the forearm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Role of endothelium-derived nitric oxide in the regulation of blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Crucial role of endothelium in the vasodilator response to increased flow in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide: an endogenous modulator of leukocyte adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Myocardial contractile effects of L-arginine in the human allograft.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Aging and endothelial function in normotensive subjects and patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endothelial function in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Expression of inducible nitric oxide synthase in human heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Hypercholesterolemia increases endothelial superoxide anion production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide synthesis in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endothelium dependent vascular relaxation by arginine containing polypeptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Vasodilatory properties of mono-L-arginine-containing compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Role of the endothelium and arginine peptides on the vaso-motor response of porcine internal mammary artery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Vascular activity of polycations and basic amino acids: L-arginine does not specifically elicit endothelium-dependent relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine evokes both endothelium-dependent and -independent relaxations in L-arginine-depleted aortas of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

l-Arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Amino acids dilate resistance blood vessels of the perfused rat mesentery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Role of endothelium-derived nitric oxide in the regulation of tonus in large-bore arterial resistance vessels, arterioles and veins in cat skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine-induced hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine-induced hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of L-arginine on forearm vessels and responses to acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

A large blood pressure-raising effect of nitric oxide synthase inhibition in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Dilator actions of arginine in human peripheral vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Regression of atherosclerosis: role of nitric oxide and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Pressor, renal and endocrine effects of l-arginine in essential hypertensives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

The vascular effects of L-Arginine in humans. The role of endogenous insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

LDLs impair vasomotor function of the coronary microcirculation: role of superoxide anions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Sex differences in endothelial function in normal and hypercholesterolaemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Chronic dietary supplementation with ?-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Dietary l-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Dietary l-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbit. Response according to treatment duration, anatomic site, and sex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Arginine: a new therapy for atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-Arginine normalizes coronary vasomotion in long-term smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-Arginine does not restore dilatation of the basilar artery during diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Aging-associated endothelial dysfunction in humans is reversed by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Basal nitric oxide production by diseased coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Basal and flow-mediated nitric oxide production by atheromatous coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of inhibition of nitric oxide synthesis in patients with coronary artery disease and stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Inhibition of nitric oxide synthesis during the cold pressor test in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Inhibition of nitric oxide synthesis in human epicardial coronary arteries and stenoses in relation to serum lipid level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Coronary stenosis dilatation induced by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Serum cholesterol level, cigarette smoking, and vasomotor responses to L-arginine in narrowed epicardial coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endothelial function of internal mammary artery in patients with coronary artery disease and in cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Nitric oxide modulation of neutrophil-endothelium interaction: difference between arterial and venous coronary bypass grafts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Arginine consumption in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Clinical and inflammatory effects of dietary L-arginine in patients with intractable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Oral L-arginine in patients with coronary artery disease on medical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Improvement of cardiac performance by intravenous infusion of l-arginine in patients with moderate congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of oral administration of L-arginine on renal function in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Continuous perivascular L-arginine delivery increases total vessel area and reduces neointimal thickening after experimental balloon dilatation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine inhibits balloon catheter-induced intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effects of L-arginine and N omega-nitro-L-arginine methyl ester on cardiac perfusion and function after 1-day cold preservation of isolated hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine: effect on reperfusion injury after heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine reduces right heart hypertrophy in hypoxia-induced pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Life-threatening hyperkalemia induced by arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

L-Arginine as an Antihypertensive Agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900736-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(00)00736-X

1 reference

4 July 2017

1 reference